Literature DB >> 14981649

Labor market costs of illness: prevalence matters.

Thomas DeLeire1, Willard Manning.   

Abstract

We present a model of the labor market effects of health impairments. In particular, we describe several economic models in which health affects worker productivity and the demand for and supply of market labor services. These models provide a framework for estimating the social cost of prevalent health impairments - a necessary step in conducting cost-benefit analyses and in determining the cost-effectiveness of potential health interventions from a broader social perspective. Our approach suggests that several measures used in the literature provide an incomplete and systematically biased assessment of the economic impact of health impairment or of the treatment of illness and impairment. The problem arises because of the reliance on an approximation at the firm level and from the bias from the neglect of the effect of impairment in shifting the labor market equilibrium. If the illness is prevalent, the effects on labor market equilibrium wage rates could be substantial. In addition, many analyses also ignore the effects of illness on producers' surplus. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 14981649     DOI: 10.1002/hec.812

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  The impact of firms' adjustments on the indirect cost of illness.

Authors:  Michał Jakubczyk; Beata Koń
Journal:  Int J Health Econ Manag       Date:  2017-02-02

Review 4.  Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment.

Authors:  Julie M Donohue; Harold Alan Pincus
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Effective HIV treatment and the employment of HIV(+) adults.

Authors:  Dana P Goldman; Yuhua Bao
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.